🔴 BioLineRx is trading 7% down in after-hours trading

BioLineRx is trading at $1.60, down 6.98% in after-hours trading; the reason for the decline remains unclear.

• No confirmed company-specific catalyst was found for the November 6 after-hours decline. The latest listed company releases were dated October 23 and October 8.
• Biotechnology ETF IBB rose 1.9% Friday, while healthcare stocks edged lower.